Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Neuroinflammation|July 16, 2024
PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammationFrida Lind-Holm Mogensen, Carole Sousa, Corrado Ameli, et al.
Glia|January 29, 2022
Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's diseasePierre Garcia, Wiebke Jürgens-Wemheuer, Oihane Uriarte Huarte, et al.
Nature Communications|January 19, 2021
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cellsClément Larrue, Nathan Guiraud, Pierre-Luc Mouchel, et al.
Cell Reports|March 29, 2026
Targeting systemic and tumor metabolic balances with ketogenic diets enhance efficacy of therapy in FLT3-ITD acute myeloid leukemiaLéa Goupille, Alexandre Boudet, Laura Lauture, et al.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
The Journal of Experimental Medicine|March 9, 2016
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemiaHéléna Boutzen, Estelle Saland, Clément Larrue, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenograftsYahaya A Yabo, Pilar M Moreno-Sanchez, Yolanda Pires-Afonso, et al.
Genome Medicine|April 2, 2024
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenograftsYahaya A Yabo, Pilar M Moreno-Sanchez, Yolanda Pires-Afonso, et al.
Cancer Discovery|July 10, 2020
Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid LeukemiaNesrine Aroua, Emeline Boet, Margherita Ghisi, et al.
Nature Cancer|February 5, 2022
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemiaClaudie Bosc, Estelle Saland, Aurélie Bousard, et al.
Pageof 5